HLeBroking

2021-11-09 09:33:13 HLIB Retail Research – 9 Nov - Bullish Tracker:

KRONO (RM0.655) , Ace market, Digital Services

Upside bias following a successful breakout above 0.645 neckline resistance

Time frame: 7 days
Entry: RM0.630-0.66
Stop Loss: RM615
Resistance: RM0.70-0.75
Target price: RM0.70-0.73
Risk profile: Moderate

Please join us on HLeBroking telegram channel: https://t.me/hlebroking1

Disclaimer: www.hlebroking.com/v3/disclaimer.asp Open / Comment

2021-11-08 06:23:53 Free registration for our upcoming Mandarin webinar happening on next Saturday, 20th Nov 2021 @ 10.30am to 12.00pm.
Register here: https://www.hlebroking.com/v3/events.aspx Open / Comment

2021-11-08 03:59:04 Technical tracker - HLIB Retail Research – 8 November 2021

JFTECH(RM1.55) – Multiple growth drivers to spur growth in FY22

Anticipate better quarters ahead. Being one of the top IP owners of high-performance test contacting solutions for global integrated circuit markers, JFTECH is set to ride on the fast-growing EV and 5G markets by supplying its patented testing socket. The group currently exports 70% of its revenue, mainly to China, US, Philippines, Thailand, etc. Despite surging 90% YoY in FY21 earnings to RM15.2m (mainly driven by organic growth), we reckon FY22 will be an explosive year for JFTECH owing to additional three growth drivers namely (1) JFH Technology Kusan (2) JFTestSense (3) M&A and partnerships.

JFH Technology Kusan. We opine that the newly established manufacturing facility (to start production in 4QCY21) with Hublle Technology Investment Co Ltd (wholly-owned subsidiaries of Huawei & Co Ltd) will enable JFTECH to design, develop, manufacture and supply high-performance test contractors in China market. This is likely to increase the group bottom line and cement its footprint and network in China.

JFTestSense. To recap, in order for JFTECH to further penetrate the testing solution value chain (for higher total ASP), JFTECH had set up a wholly-owned subsidiary JFTestSense to provide test software solutions together with other test interface products such as stiffener, probe card, etc. This division is expected to start contributing from 1QFY22.

M&A and partnerships. The recent agency agreements with ISC Co. Ltd (“ISC”) on 11 Aug 2021 is expected to provide a strong synergy to JFTECH to become a complete one-stop solution to its customers by possessing all four major tests socket offerings. As JFTECH is able to offer all four major test sockets under one roof, every semiconductor manufacturing companies could potentially become a client to JFTECH. With China continuing to pursue self-sufficiency in semiconductors on the back of national strategic and security interests, JFTECH’s outlook is expected to remain promising following the strategic alliance.

Pending a bullish Cup and handle (C&H) pattern. After plunging 58% from a high of RM2.41 (21 Jan) to a low of RM1.01 (31 March), JFTECH staged a sharp rebound to close at RM1.55 yesterday. Currently, the stock is awaiting a C&H formation, with indicators showing uptick bias. A successful breakout above its neckline (RM 1.57) will spur the prices toward RM 1.70-1.75-1.80 territory. Cut loss at RM 1.41.

Collection range: RM1.48-1.52-1.56

Upside targets: RM1.70-1.75-1.80

Cut loss: RM1.45

Please join us on HLeBroking telegram channel: https://t.me/joinchat/qaZOqmjEU0k4ZGVl

DISCLAIMER: https://www.hlebroking.com/v3/disclaimer.aspx Open / Comment

2021-11-05 03:49:51 HLIB Retail Research – 5 Nov - Bullish Tracker:

DPIH (RM0.44) , Ace market, Consumer Products & Services

A well-established aerosol manufacturer in Malaysia; Technical showing uptick bias.

Time frame: 7 days
Entry: RM0.415-0.445
Stop Loss: RM0.40
Resistance: RM0.455-0.495-0.535
Target price: RM0.48-0.50
Risk profile: Moderate

Please join us on HLeBroking telegram channel: https://t.me/hlebroking1

Disclaimer: www.hlebroking.com/v3/disclaimer.asp Open / Comment

2021-11-05 03:43:59 Technical tracker - HLIB Retail Research – 5 Nov 2021

FLBHD (RM0.94-Not rated) – Anticipate stronger quarters ahead; Poised for a downtrend line breakout

FLBHD (listed in April 2011) is a high-quality plywood producer in Malaysia with many accreditations from reputable international bodies. It focuses on the manufacturing and sale of plywood (generate over 95% to FY20 revenue), veneer and laminated veneer lumber (LVL). The group is also reusing bulk waste to generate biomass energy to supply electricity to its operation. FLBHD exports over 95% of its products, mainly to the US (76% of FY20 vs 66% in FY19), Taiwan (7% of FY20), Thailand (5% of FY20), HK (4%), Japan (2%) and others (6%). Major competitors are coming from Vietnam, Indonesia and China.

Promising North America RV industry outlook.FLBHD will continue to expand its customer base in the US lucrative recreational vehicles (RV) sector, which contributes over 60% to its US sales. According to the Research & Market report, the RV market was valued at USD31bn in 2020, and it is expected to reach USD48bn by 2026, registering a CAGR of 7% during the forecast period (2021 - 2026). On the back of the Covid-19, the global RV market is expected to witness strong growth, especially in North America and Europe. As these vehicles provide a reliable and personal way to travel, it is considered the safest travel alternative during the pandemic, while maintaining social distance norms.

The worst is likely over.We believe the positive momentum in 2Q21 is likely to filter through in 2H21 and FY22 (despite the 2-month lockdown in July/Aug) riding on 1) the improving operating business environment since Sep; 2) promising RV prospects; 3) high ASP of wood-related products; 4) favourable RM/US$ (HLIB: RM4.16 average for 2021); 5) sustainable logs supplies. FLBHD is currently trading at 0.58x PB (18% discount against its peers and 28% lower than 10Y average), supported by strong netcash/share of RM0.78 and potential dividend payout in F21 in anticipation of a better 2H21 and solid balance sheet. To recap, FLBHD declared 3-5sen dividend (or 3.2-5.3% DY) in FY19-20 despite incurring losses.

Poised for a downtrend line breakout. After sliding 23% from 52-week high RM1.22 to RM0.94 (3 Nov), we expect FLBHD to stage a downtrend line (DTL) resistance breakout (near RM0.95) soon as the stock continues to trend firmly above key MAs. A successful DTL breakout would spur share prices toward RM1.00 and RM1.05 (30 Aug) before hitting our LT objective of RM1.22. Collection range is RM0.88-0.95 whilst cut loss is pegged at RM0.87 zones.

*Collection range: RM0.88-0.93-0.95*

*Upside targets: RM0.99-1.05-1.22*

*Cut loss: RM0.87*

Please join us on HLeBroking telegram channel: https://t.me/joinchat/qaZOqmjEU0k4ZGVl


DISCLAIMER: https://www.hlebroking.com/v3/disclaimer.aspx Open / Comment

2021-11-03 16:15:01 Happy Deepavali! May this festival of lights illuminate your life with peace, happiness and good health.  Open / Comment

2021-11-03 08:26:26 Bullish Tracker Results for October

We’ve achieved another % successful hit rate and 6.6% return !

Start trading today with HLeBroking: www.hlebroking.com.

——————————————————

Please join us on HLeBroking telegram channel: https://t.me/hlebroking1

Disclaimer: www.hlebroking.com/v3/disclaimer.aspx Open / Comment

2021-11-03 04:17:18 HLIB Retail Research – 3 Nov - Bullish Tracker:

TEXCYCL (0.465) , Ace market, Industrial Services

Technical showing reversal sign, indicators showing uptick bias

Time frame: 7 days
Entry: RM0.445-0.47
Stop Loss: RM0.435
Resistance: RM0.49-0.53-0.575
Target price: RM0.50-0.53
Risk profile: Moderate

Please join us on HLeBroking telegram channel: https://t.me/hlebroking1

Disclaimer: www.hlebroking.com/v3/disclaimer.asp Open / Comment

2021-11-03 04:03:02 Technical tracker - HLIB Retail Research – 3 November 2021

PHARMA (RM0.795, HLIB BUY – TP RM1.13) – Beneficiary of higher allocation to MOH

PHARMA will be one of the winners in the Budget 2022 amid higher allocation to MOH in 2022 of RM32.4bn (+1.6% YoY), thanks to its role as the sole concession holder to distribute drugs and consumables to public hospitals and clinics, as well as the increased drug purchase.

Although there is no clear sign on whether Sinovac will be allowed to be one of the boosters shot, we do not rule out the possibility of Pharma potentially supplying vaccines to the government again. Any green light from the government to use Sinovac as booster shot is expected to catalyse share price.

In addition, the recent non-binding MOU with the National Institute of Biotechnology Malaysia (NIBM) is expected to augur well for PHARMA’s plans to establish the world’s first halal vaccine manufacturing plant in Malaysia, which is in line with the Malaysian government’s plan. Under this non-binding MOU, both parties will be providing technical services particularly on the R&D of vaccines.

After tumbling 41% from a high of RM1.41 (1 Jun) to a low of RM0.79 (20th July), the stock has staged a steady recovery to end at RM0.80. PHARMA is currently trading at an undemanding valuation of 15.6x FY22 P/E (39% discount against its 5-year P/E of 25.8x) together will generous FY22 dividend yield of 4.1%. Going forward, PHARMA is in discussions with Sinovac Biotech Ltd to facilitate the export of the vaccine to countries that face challenges in securing sufficient supply, including Indonesia, The Philippines, Cambodia, Thailand, as well as several African nations. Beyond the Covid-19 vaccine, the group will continue to focus on its Indonesia market through the expansion of its distribution coverage coupled with strong products in the pipeline.

Technically, PHARMA is building a sound base near RM0.76-79 territory, which we believe would offer buying opportunity. A strong breakout above RM0.85 (200D MA) will spur the prices toward RM0.93-RM1.04 territory. Cut lost at RM0.70.

Collection range: RM0.75-0.78-0.795

Upside targets: RM0.85-0.90-1.00

Cut loss: RM0.72

Please join us on HLeBroking telegram channel: https://t.me/joinchat/qaZOqmjEU0k4ZGVl

DISCLAIMER: https://www.hlebroking.com/v3/disclaimer.aspx Open / Comment

2021-11-02 03:00:52 Dear Valued Client,

We wish to inform you that you will receive a Touch 'n Go Reload PIN worth up to RM500* if, during the Campaign Period (1st November 2021 to 28th February 2022), you successfully refer a new customer* to open a new HLeBroking Account.

To find out more, please refer to the HLeBroking Clients Referral Campaign's terms and conditions available at the HLeBroking website: https://www.hlebroking.com.

*Subject to the HLeBroking Clients Referral Campaign's terms and conditions. Open / Comment